PPM1K and maple syrup urine disease: Previous studies have shown that a regulatory defect in BCKDC due to loss of the BCKDC phosphatase (PP2Cm) leads to a partial reduction in BCKDC activity and elevations of plasma BCKAs and BCAAs [68] leading to an intermittent form of Maple Syrup Urine Disease [68], [69], [70].